Widhopf George F, Goldberg Craig J, Toy Traci L, Rassenti Laura Z, Wierda William G, Byrd John C, Keating Michael J, Gribben John G, Rai Kanti R, Kipps Thomas J
Chronic Lymphocytic Leukemia Research Consortiuim, La Jolla, CA, USA.
Blood. 2008 Mar 15;111(6):3137-44. doi: 10.1182/blood-2007-02-073130. Epub 2007 Aug 3.
We analyzed the immunoglobulin (Ig) variable heavy (IGHV) and variable light chain genes used by leukemia cells of 258 unrelated patients with chronic lymphocytic leukemia (CLL) found to express unmutated Ig heavy chains (IgH) encoded by a 51p1 allele of IGHV1-69 among 1846 CLL patients examined. We found each had at least 98% homology to an identified germline IGKV or IGLV gene. Within the 258 IgH, we identified heavy chain CDR3 (HCDR3) motifs encoded by certain unmutated IGHD and IGHJ genes with restricted reading frames. Frequent and restricted use of particular IGKV and IGLV genes revealed nonstochastic pairing of disparate Ig light chains (IgL) with IgH that had restricted HCDR3 motifs designated CLL69A, -B, -C, and -D. Eighty-six percent (19/22) of CLL cases that expressed motif CLL69B encoded by IGHD2-2/IGHJ6 had distinctive IgL encoded by IGKV1-39. Similarly, 83% (5/6) of samples with motif CLL69D encoded by IGHD2-2/IGHJ6 expressed IGKV3-11, 100% (25/25) with motif CLL69A encoded by IGHD3-16/IGHJ3 used IGKV3-20, and 77% (10/13) with motif CLL69C encoded by IGHD3-3/IGHJ6 expressed IGLV3-9. This study reveals nonstochastic pairing of IgH with particular IgL that is predicated upon Ig HCDR3 structure, providing compelling evidence for selection of antibodies expressed in CLL by conventional antigens.
我们分析了258例无关慢性淋巴细胞白血病(CLL)患者白血病细胞所使用的免疫球蛋白(Ig)重链可变区(IGHV)和轻链可变区基因,这些患者在1846例接受检测的CLL患者中,其Ig重链(IgH)由IGHV1-69的51p1等位基因编码且未发生突变。我们发现每个基因与已鉴定的种系IGKV或IGLV基因至少有98%的同源性。在这258条IgH中,我们鉴定出由某些未突变的IGHD和IGHJ基因编码的重链互补决定区3(HCDR3)基序,其阅读框受限。特定IGKV和IGLV基因的频繁且受限使用揭示了不同的Ig轻链(IgL)与具有受限HCDR3基序(命名为CLL69A、-B、-C和-D)的IgH之间的非随机配对。86%(19/22)表达由IGHD2-2/IGHJ6编码的基序CLL69B的CLL病例具有由IGKV1-39编码的独特IgL。同样,83%(5/6)具有由IGHD2-2/IGHJ6编码的基序CLL69D的样本表达IGKV3-1, 100%(25/25)具有由IGHD3-16/IGHJ3编码的基序CLL69A的样本使用IGKV3-20,77%(10/13)具有由IGHD3-3/IGHJ6编码的基序CLL69C的样本表达IGLV3-9。本研究揭示了IgH与特定IgL之间的非随机配对,这种配对取决于Ig HCDR3结构,为传统抗原在CLL中表达的抗体选择提供了有力证据。